Form 8-K - Current report:
SEC Accession No. 0000950123-08-013744
Filing Date
2008-10-29
Accepted
2008-10-29 08:25:20
Documents
7
Period of Report
2008-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y72186e8vk.htm 8-K 12128
2 EX-10.1: JOINT PRESS RELEASE y72186exv10w1.htm EX-10.1 10957
3 EX-10.2: SECOND AMENDMENT TO CREDIT AGREEMENT y72186exv10w2.htm EX-10.2 225881
4 EX-10.3: FIRST AMENDMENT TO CREDIT AGREEMEMT y72186exv10w3.htm EX-10.3 133230
5 GRAPHIC y72186y7218601.gif GRAPHIC 2726
6 GRAPHIC y72186y7218602.gif GRAPHIC 2094
7 GRAPHIC y72186y7218603.gif GRAPHIC 4027
  Complete submission text file 0000950123-08-013744.txt   396436
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Filer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-09860 | Film No.: 081146371
SIC: 2834 Pharmaceutical Preparations